Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Rhode Island 25 trials found
New Search
Filter
Trial Phase
Study Type
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
NAINTERVENTIONAL Palo Alto, California +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
PHASE1, PHASE2INTERVENTIONAL Camberwell +4 more
RECRUITING
Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
PHASE2INTERVENTIONAL Bayswater, Victoria
RECRUITING
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
PHASE3INTERVENTIONAL Santa Barbara, California +4 more
RECRUITING
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
PHASE1, PHASE2INTERVENTIONAL Melbourne
RECRUITING
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
PHASE3INTERVENTIONAL Sydney, New South Wales +4 more
RECRUITING
Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
PHASE1INTERVENTIONAL Heidelberg, Victoria +2 more
RECRUITING
Closed-loop in Adults With Type 2 Diabetes
NAINTERVENTIONAL Melbourne +4 more
RECRUITING
Pasteurised Donor Human Milk Supplementation for Term Babies
PHASE4INTERVENTIONAL Brisbane, Queensland +3 more
RECRUITING
EValuation Of poLygenic Scores and CT imAging In Risk Factor Modification in Patients With diabEtes
NAINTERVENTIONAL Melbourne, Victoria
RECRUITING
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
NAINTERVENTIONAL Melbourne +4 more
RECRUITING
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
PHASE3INTERVENTIONAL Aurora, Colorado +4 more
RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Guntersville, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type